Skip to main content
Premium Trial:

Request an Annual Quote

NanoCellect Biomedical, Daon BioSciences Sign Korean Distribution Agreement

NEW YORK (GenomeWeb) – NanoCellect Biomedical announced today that it has signed a distribution agreement with Seoul-based Daon Biosciences in the South Korean market.

NanoCellect's Wolf Cell Sorter and N1 single-cell plate dispenser uses lasers and piezoelectricity to help researchers gently sort cells to maintain their viability. According to NanoCellect, researchers are using the platform in antibody discovery, cell line development, genomic sample preparation, CRISPR genomic editing, and plant and animal genomics.

"We believe that our products complement [Daon's] current portfolio and will greatly enhance their ability to improve the research workflows for their customers," NanoCellect CEO Chris Neary said in a statement. "We were also impressed with the positive feedback from their existing partners and customers in Korea."

Financial details of the agreement were not disclosed.

"NanoCellect's Wolf platform will enable our customers to significantly advance their research by providing gentle cell sorting in sterile microfluidic cartridges," Daon CEO Sujin Kim said in a statement. "The Wolf platform will address an unmet need of many of our research customers, advancing single-cell genomics and cloning applications in Korea."